PHONE: (414) 333-3873

Author archive for John Reimer

  • Uncategorized

    Press Release

    - by John Reimer

    John Reimer New Vice President of Business Development for BioMed ENT


    – BioMed ENT, a prominent player in the Ear, Nose, and Throat (ENT) healthcare industry, is pleased to announce the appointment of John Reimer as the new Vice President of Business Development, overseeing its United States operations. This strategic move aligns with BioMed ENT’s vision of expanding its innovative medical solutions in the ENT space, leveraging John’s extensive experience and the collective leadership approach he cultivated at Xiogenix.

    At Xiogenix, John was part of a dynamic leadership team that included Rachel Bahr and Jerry Jendusa, from whom he gained invaluable insights. Together, they propelled Xiogenix to new heights, nurturing a culture of collaboration and innovation. This team-centric approach led to significant advancements in bioscience, particularly in tissue banking and cell therapy, showcasing the power of collective effort in achieving corporate success and industry breakthroughs.

    Tonny Voermans, President of BioMed ENT, expressed enthusiasm about John’s appointment, stating, “We are thrilled to welcome John to our team. His experience in harnessing the strength of collaborative leadership and his proven track record in the bioscience field are exactly what BioMed ENT needs to enhance our presence and impact in the U.S. ENT market.”

    In his new role, John is tasked with driving BioMed ENT’s business development initiatives in the United States, focusing on introducing innovative solutions that address the complex needs of the ENT healthcare sector. His leadership is anticipated to foster a culture of innovation and teamwork, mirroring the successful strategies employed at Xiogenix.

    “I am excited to join BioMed ENT and contribute to its mission of advancing ENT healthcare through innovation,” said John Reimer. “The opportunity to lead the U.S. operations and work with a talented team to deliver impactful solutions is incredibly motivating. I look forward to building on the collaborative leadership approach I experienced at Xiogenix to achieve great things at BioMed ENT.”

    BioMed ENT is dedicated to improving patient outcomes and enhancing the efficiency of ENT healthcare services with its cutting-edge solutions. With John Reimer at the helm of its U.S. business development, the company is poised for significant growth and continued innovation in the ENT field.


  • Product Training

    Strategic Engagements

    - by John Reimer

    Strategic Engagements and Demonstrations with Industry Partners

    In the last two weeks, Tonny Voermens and I have conducted a series of targeted meetings and training sessions across the United States, focusing on showcasing Biomed ENT’s innovative product lineup to our industry partners. These engagements have provided valuable opportunities for in-depth product discussions, hands-on training, and receiving direct feedback from medical professionals.

    • Our tour commenced in Atlanta, where we met with Mitch Gutierrez from Century Medical Supplies. The focus was on discussing the clinical applications and advantages of our ENT products.

    • We then traveled to Miami for sessions with Randy Carmona of RJC Medical and Jeff Fuelner from Florida Micro Surgical, exploring the practical use and reception of our products by healthcare providers.

    • In Austin, a standout moment was participating in surgery observations with Javier Herrera. Here, Tonny and I had the opportunity to demonstrate Biomed ENT’s products during actual surgical procedures, engaging directly with ENT doctors in the operating room. This hands-on experience was crucial for showcasing the real-world benefits of our offerings.

    • Following Austin, we visited Houston to engage with Jody Brower and Bill Flowers from Five Points Medical. Our discussions centered on market insights and product demand projections, ensuring our offerings meet the evolving needs of ENT specialists.

    • Our next stop was Philadelphia, where we held a productive meeting with Sean Hardon from Envision, along with Mike DeMaria, Michael DeMaria, and Chris O’Neill from MD Surgical. This session provided comprehensive training on our product range, emphasizing the unique benefits and integration strategies for the market.

    • The series of engagements concluded in Washington D.C., meeting Kimberly Arrizi and Mike Wheeler from Eclipse Surgical. These discussions offered insights into regulatory aspects and strategies for market adoption of our products.

    Each meeting, especially the direct interactions and live demonstrations in Austin, was invaluable for understanding the practical impact and benefits of our products from the perspectives of end-users. These engagements have not only allowed us to validate the effectiveness of our products but also to gather essential feedback from ENT professionals, enhancing our strategies for serving the market and advancing ENT care solutions.

    Sean Hardon, Mike DeMaria, Chris O'Neill, Michael DeMaria, Tonny Voermans

    About Biomed ENT:

    Biomed ENT is at the forefront of innovative Ear, Nose, and Throat (ENT) care, dedicated to enhancing patient outcomes through cutting-edge medical solutions. Our product portfolio, including the EpiPatch, MyringoPatch, and Epi-Stop Nasal Gel, embodies our commitment to pioneering advancements in ENT treatment. Developed with the insights of leading medical professionals, each product is designed to offer minimally invasive, effective alternatives for ENT conditions, improving the quality of care for patients worldwide.

    At Biomed ENT, we believe in the power of innovation to transform patient care. Our mission is to continuously explore and develop new technologies that address the unmet needs of the ENT community. By fostering close collaborations with healthcare professionals and staying abreast of the latest research, we ensure our products not only meet but exceed the evolving demands of ENT healthcare.

    For more information about our products and how we’re revolutionizing ENT care, visit our website or contact us directly. Join us in our journey to set new standards in ENT treatment and make a lasting difference in patients’ lives.